• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国两个医疗系统中按HIV感染状况划分的心肌梗死风险趋势。

Trends in Myocardial Infarction risk by HIV status in two U.S. healthcare systems.

作者信息

Lea Alexandra N, Lyass Asya, Hurley Leo B, Ehrbar Rachel Q, Mahoney Taylor F, Borowsky Leila H, He Wei, Plutzky Jorge, Triant Virginia A, Silverberg Michael J

机构信息

Division of Research, Kaiser Permanente Northern California, Pleasanton, California, United States of America.

Department of Mathematics and Statistics, Boston University, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2025 Jun 23;20(6):e0325773. doi: 10.1371/journal.pone.0325773. eCollection 2025.

DOI:10.1371/journal.pone.0325773
PMID:40549744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12184993/
Abstract

People with HIV have a higher risk of myocardial infarction (MI) compared with people without HIV. Real world evidence on whether the increased burden of MI in people with HIV is sustained over time is essential for understanding cardiovascular disease (CVD) patterns, optimizing management, and identifying unmet needs. To help fill this gap, we completed a cohort study of people with HIV and propensity matched people without HIV in two distinct US-based integrated healthcare systems (Kaiser Permanente Northern California and Mass General Brigham). Electronic health records were assessed for association of HIV status on MI risk in two calendar eras defined by baseline year: 2005-2009 and 2010-2017, with maximum 5-year follow-up, through 2020. Cox proportional hazards models were used to obtain adjusted hazard ratios (HR) for HIV status on MI risk overall and by cohort. Adjusted models controlled for demographics and traditional CVD risk factors. We included 9,401 people with HIV (78 with MI) and 29,418 people without HIV (204 with MI). In adjusted models, the HR for MI in people with HIV was 1.10 (95% CI, 0.76, 1.60) for years 2005-2009 and 1.66 (95% CI, 1.15, 2.39) for years 2010-2017 compared with people without HIV, with a corresponding P-interaction between HIV status and calendar era of 0.12. Differences were largely due to decreases in MI risk for people without HIV. The magnitude of HRs by calendar era was consistent across models stratified by cohort. Results showed an increased MI risk persisted among people with HIV in recent years relative to people without HIV, even as CVD rates are decreasing in the general population. In light of known HIV-specific CVD risk factors, continued surveillance for MIs is merited.

摘要

与未感染艾滋病毒的人相比,感染艾滋病毒的人患心肌梗死(MI)的风险更高。关于艾滋病毒感染者心肌梗死负担增加是否会随着时间持续存在的真实世界证据,对于理解心血管疾病(CVD)模式、优化管理以及确定未满足的需求至关重要。为了填补这一空白,我们在美国两个不同的综合医疗系统(北加利福尼亚凯撒医疗集团和麻省总医院布莱根分院)中,对感染艾滋病毒的人和倾向匹配的未感染艾滋病毒的人进行了一项队列研究。通过电子健康记录评估了在以基线年份定义的两个日历时期(2005 - 2009年和2010 - 2017年)中,艾滋病毒感染状况与心肌梗死风险的关联,并进行了最长5年的随访,直至2020年。使用Cox比例风险模型来获得艾滋病毒感染状况对总体心肌梗死风险以及按队列划分的心肌梗死风险的调整后风险比(HR)。调整后的模型控制了人口统计学因素和传统的心血管疾病风险因素。我们纳入了9401名感染艾滋病毒的人(78人发生心肌梗死)和29418名未感染艾滋病毒的人(204人发生心肌梗死)。在调整后的模型中,与未感染艾滋病毒的人相比,2005 - 2009年感染艾滋病毒的人发生心肌梗死的HR为1.10(95%CI,0.76,1.60),2010 - 2017年为1.66(95%CI,1.15,2.39),艾滋病毒感染状况与日历时期之间相应的P交互作用为0.12。差异主要是由于未感染艾滋病毒的人心肌梗死风险降低。按日历时期划分的HR大小在按队列分层的模型中是一致的。结果显示,近年来与未感染艾滋病毒的人相比,感染艾滋病毒的人发生心肌梗死的风险持续增加,尽管普通人群中心血管疾病发病率正在下降。鉴于已知的艾滋病毒特异性心血管疾病风险因素,值得继续对心肌梗死进行监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ab/12184993/942cd1397f86/pone.0325773.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ab/12184993/942cd1397f86/pone.0325773.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ab/12184993/942cd1397f86/pone.0325773.g001.jpg

相似文献

1
Trends in Myocardial Infarction risk by HIV status in two U.S. healthcare systems.美国两个医疗系统中按HIV感染状况划分的心肌梗死风险趋势。
PLoS One. 2025 Jun 23;20(6):e0325773. doi: 10.1371/journal.pone.0325773. eCollection 2025.
2
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
3
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.
4
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.
5
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
6
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.
7
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6.
8
Electronic cigarettes for smoking cessation.用于戒烟的电子烟。
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.
9
Patient education in the management of coronary heart disease.冠心病管理中的患者教育
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3.
10
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub8.

本文引用的文献

1
Changes in Body Mass Index Over Time in People With and Without HIV Infection.感染HIV和未感染HIV人群的体重指数随时间的变化
Open Forum Infect Dis. 2024 Feb 6;11(2):ofad611. doi: 10.1093/ofid/ofad611. eCollection 2024 Feb.
2
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management.艾滋病毒感染者中心血管疾病的发病机制和临床表现的演变:对治疗的影响。
Clin Microbiol Rev. 2024 Mar 14;37(1):e0009822. doi: 10.1128/cmr.00098-22. Epub 2024 Feb 1.
3
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
匹伐他汀预防 HIV 感染患者的心血管疾病。
N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23.
4
Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States.在接受整合酶抑制剂与非整合酶抑制剂抗逆转录病毒疗法治疗的 HIV-1 感染者中,心代谢结局的发生率:美国保险索赔的回顾性分析。
J Int AIDS Soc. 2023 Jun;26(6):e26123. doi: 10.1002/jia2.26123.
5
The epidemiology, mechanisms, diagnosis and treatment of cardiovascular disease in adult patients with HIV.成年HIV患者心血管疾病的流行病学、发病机制、诊断与治疗
Am J Cardiovasc Dis. 2023 Apr 15;13(2):101-121. eCollection 2023.
6
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.在感染 HIV 的人群中,整合酶抑制剂与心血管疾病之间的关联:来自 RESPOND 队列联盟的一项多中心前瞻性研究。
Lancet HIV. 2022 Jul;9(7):e474-e485. doi: 10.1016/S2352-3018(22)00094-7. Epub 2022 Jun 7.
7
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
8
Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study.在英国,有和没有人类免疫缺陷病毒的人群中心血管代谢疾病的发病率:一项基于人群的匹配队列研究。
J Infect Dis. 2022 Apr 19;225(8):1348-1356. doi: 10.1093/infdis/jiab420.
9
Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations.评估 HIV 感染者的心血管风险:现有工具及局限性。
Curr HIV/AIDS Rep. 2021 Aug;18(4):271-279. doi: 10.1007/s11904-021-00567-w. Epub 2021 Jul 11.
10
Mechanisms and primary prevention of atherosclerotic cardiovascular disease among people living with HIV.HIV 感染者的动脉粥样硬化性心血管疾病发病机制和一级预防。
Curr Opin HIV AIDS. 2021 May 1;16(3):177-185. doi: 10.1097/COH.0000000000000681.